| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 54.05B | 55.58B | 52.95B | 49.48B | 44.82B | 38.81B |
| Gross Profit | 12.66B | 13.92B | 12.21B | 11.40B | 9.61B | 8.66B |
| EBITDA | 5.61B | 5.78B | 5.70B | 4.96B | 4.27B | 5.57B |
| Net Income | 2.66B | 3.16B | 2.47B | 2.25B | 1.77B | 2.14B |
Balance Sheet | ||||||
| Total Assets | 67.55B | 74.56B | 67.07B | 63.07B | 60.63B | 58.94B |
| Cash, Cash Equivalents and Short-Term Investments | 7.07B | 6.18B | 5.93B | 5.97B | 9.99B | 11.11B |
| Total Debt | 3.03B | 6.40B | 3.56B | 2.33B | 3.01B | 4.20B |
| Total Liabilities | 17.47B | 20.89B | 17.61B | 15.68B | 15.72B | 15.94B |
| Stockholders Equity | 50.08B | 53.67B | 49.46B | 47.39B | 44.91B | 42.98B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.56B | 324.00M | -2.83B | -174.00M | 2.28B |
| Operating Cash Flow | 0.00 | 4.79B | 4.70B | 3.66B | 3.50B | 3.95B |
| Investing Cash Flow | 0.00 | -7.17B | -5.29B | -6.47B | -3.31B | 2.63B |
| Financing Cash Flow | 0.00 | 2.39B | 554.00M | -1.23B | -1.36B | -1.43B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥194.62B | 5.05 | ― | 1.84% | 18.74% | 223.25% | |
74 Outperform | ¥15.93B | 10.60 | ― | 3.37% | 2.44% | 3.81% | |
72 Outperform | ¥24.02B | 3.71 | ― | 1.81% | 4.96% | 27.69% | |
72 Outperform | ¥26.07B | 9.39 | ― | 2.33% | 20.46% | 45.70% | |
69 Neutral | ¥18.97B | 7.10 | ― | 2.46% | -0.28% | 15.95% | |
65 Neutral | ¥7.53B | 20.91 | ― | 1.24% | -2.83% | 183.28% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |